Contact us

Implants CDMO Companies
Implants Contract Manufacturing Services

Your Trusted Partners for Implants Contract Manufacturing and Development

Applied Filters:Implants×FDF / DRUG PRODUCTS×Clear All
Showing 11 facilities
EVER Pharma Jena GmbH
Germany

EVER Pharma Jena GmbH

EVER Neuro Pharma GmbH

Specialized CDMO for development and production of small molecules injectables.

Discover our facility

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small, Medium, Large

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), NMPA (China GMP), ISO, TITCK (Turkish Health Authorities), MFDS/KFDA (Republic of Korea GMP)

CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

REGION: Europe

USE: Human

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (N) Nervous system

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

BSL (Biological Safety Level): 1, 2

Green Phoenix Labs GmbH
Germany

Green Phoenix Labs GmbH

Green Phoenix Labs GmbH

Cell Therapy company with excess Cleanroom capacity.

Discover our facility

BATCH SIZE: Small, Medium

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, SERVICES, BIOLOGICS

COMPLIANCE: EMA (EU GMP)

CONTROLLED SUBSTANCES: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse

REGION: Europe

USE: Human

SERVICES: Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

BSL (Biological Safety Level): 1

MARKETS: EMA (EU)

Sichuan Huiyu Pharmaceuticals Co., Ltd. - R&D Site
China

Sichuan Huiyu Pharmaceuticals Co., Ltd. - R&D Site

Seacross Pharmaceutical Co Ltd

The R&D Center plays a fundamental role in supporting the development of both APIs and finished dosage forms.

Discover our facility

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small, Medium, Large

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC

COMPLIANCE: ISP (Chile BPM), Roszdravnadzor (Russia GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), IFS, DIGEMID, UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), French Service-Public (CIR), TGA (Australia GMP), FDA (cGMP), NSF, NMPA (China GMP), SFDA (Saudi Food & Drug Authority), BRCGS, ECOVADIS, ISO, Halal Research Council, INVIMA, Health Canada (Canada GMP), SQF (Safe Quality Food), TITCK (Turkish Health Authorities), MSPAS, MFDS/KFDA (Republic of Korea GMP), COFEPRIS

CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

BSL (Biological Safety Level): 3, 4, 1, 2

USE: Human

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

REGION: APAC

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Sichuan Huiyu Pharmaceuticals Co., Ltd. - Formulation Manufacturing Site
China

Sichuan Huiyu Pharmaceuticals Co., Ltd. - Formulation Manufacturing Site

Seacross Pharmaceutical Co Ltd

The Formulation Manufacturing Site is dedicated to the development and production of complex, high-value dosage forms.

Discover our facility

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small, Medium, Large

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, SERVICES

COMPLIANCE: ISP (Chile BPM), Roszdravnadzor (Russia GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), IFS, DIGEMID, UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), French Service-Public (CIR), TGA (Australia GMP), FDA (cGMP), NSF, NMPA (China GMP), SFDA (Saudi Food & Drug Authority), BRCGS, ECOVADIS, ISO, Halal Research Council, INVIMA, Health Canada (Canada GMP), SQF (Safe Quality Food), TITCK (Turkish Health Authorities), MSPAS, MFDS/KFDA (Republic of Korea GMP), COFEPRIS

CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

BSL (Biological Safety Level): 3, 4, 1, 2

USE: Human

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

REGION: APAC

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Register
Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Solutions for non Viral Delivery programs

Location available after registration

Register for freeContact MAI to connect
Register
Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

EU-GMP-certified CMO based in Martin, Slovakia. The company provides manufacturing and packaging servicesfor sterile pharm. products and solid oral dosage forms

Location available after registration

Register for freeContact MAI to connect
Register
Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

One-stop CDMO Solutions for APl and Key intermediates.

Location available after registration

Register for freeContact MAI to connect

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+4 more facilities

Create free account

Implantable drug delivery systems offer controlled, long-acting, and site-specific release of active pharmaceutical ingredients, providing therapeutic benefits across oncology, pain management, contraception, ophthalmology, and more. Due to technical complexity and strict regulatory requirements, successful development depends on working with experienced implants CDMO companies.

With expertise in formulation, device integration, and aseptic production, specialized implants contract manufacturing partners help pharmaceutical and medtech innovators bring safe, effective, and scalable implantable products to market.

How to Choose Implants CDMO Companies

When selecting among implants CDMO companies, key evaluation points include:

  • Material expertise: Biodegradable polymers (e.g., PLGA, PLA), silicones, and titanium-based systems
  • Manufacturing technologies: Extrusion, compression molding, hot melt, injection molding, and 3D printing
  • Combination product capabilities: Integration of drug and device elements
  • Sterilization experience: E-beam, gamma, or aseptic processing
  • Regulatory compliance: Familiarity with FDA, EMA, MDR, and ISO 13485 standards
  • Support for complex filing types: IND/NDA, IDE/PMA, 505(b)(2), or medical device pathways

A qualified CDMO ensures implant safety, reliability, and long-term performance.

Key Services Offered by Implants Contract Manufacturers

Full-service implants contract manufacturing providers typically offer:

  • Formulation development: For long-acting and biodegradable implants
  • Device prototyping and scale-up: Using custom tooling and 3D printing
  • Aseptic and terminal sterilization: Compatible with sensitive APIs
  • Combination product development: Drug + device under QMS
  • In vitro release testing and stability studies
  • Container closure and packaging design: For implant kits or single-use systems
  • Regulatory support: For drug-device submissions
  • GMP manufacturing: For clinical and commercial scale

These services support innovation while ensuring the safety and consistency of complex implantable systems.

Advantages of Partnering with Implants CDMO Companies

Working with top-tier implants CDMO companies offers key advantages:

  • Controlled, site-specific drug delivery: For improved therapeutic outcomes
  • Extended-release profiles: Reduce dosing frequency and improve adherence
  • Integrated device and drug development: To accelerate timelines
  • Regulatory clarity: With combination product experience
  • Flexible manufacturing options: From early development through market launch

The right CDMO minimizes technical and regulatory risks across the product lifecycle.

Implants CDMO Companies

Some of the most trusted implants CDMO companies include:

  • Sichuan Huiyu Pharmaceuticals: Specializes in CMO/CDMO services for APIs and complex injectables, including implants, liposomes, high-potency, oncology, cytotoxic, and corticosteroid drugs. [See CDMO profile]
  • Ascil Biopharm: A GMP facility fully equipped for R&D and pharmaceutical development. [See CDMO profile]
  • i+Med: Developer and manufacturer of new drug products with controlled-release technologies. [See CDMO profile]
  • Green Phoenix Labs GmbH: Cell therapy company offering excess cleanroom capacity to support advanced pharmaceutical and biotechnological manufacturing activities. [See CDMO profile]

Related Information

Let MAI CDMO Help You Find the Right Implants CDMO Partner

At MAI CDMO, we connect pharmaceutical and medtech companies with the most experienced implants CDMO companies worldwide. Whether you’re creating a subcutaneous implant, an ocular insert, or a long-acting drug-eluting system, our network of implants contract manufacturing partners is equipped to bring your innovation to life — safely, efficiently, and compliantly.

Need help bringing your implantable product to market? Contact us today to find the ideal CDMO.